Skip to main content Back to Top
Advertisement

6/15/2020

Sodium Phosphate Injection

Products Affected - Description

    • Sodium Phosphate injection, Pfizer, 3 mmol/mL, 15 mL vial, 25 count, NDC 00409-7391-72

Reason for the Shortage

    • American Regent is not currently marketing sodium phosphate injection.[1]
    • Fresenius Kabi has sodium phosphate injection available.[2]
    • Pfizer has sodium phosphate injection on shortage due to manufacturing delay.[3]

Available Products

    • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 15 mL vial, 25 count, NDC 63323-0170-15
    • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 5 mL vial, 25 count, NDC 63323-0170-05
    • Glycophos injection, Fresenius Kabi, 1 mmol/mL, 20 mL vial, 10 count, NDC 63323-0241-20

Estimated Resupply Dates

    • Pfizer has sodium phosphate 3 mmol/mL 15 mL vials on back order and the company estimates a release date of August 2020.[3]

Implications for Patient Care

    • Phosphate injection products are used to treat and prevent hypophosphatemia.[4]

Alternative Agents & Management

    • In cooperation with FDA, Fresenius Kabi USA is providing Glycophos (sodium glycerophosphate) injection to the US market to help alleviate the shortage of phosphate injections. Glycophos is manufactured in an FDA-approved facility in Norway by Fresenius Kabi AG. Details can be found on https://www.fda.gov/downloads/drugs/drugsafety/drugshortages/ucm591758.pdf

References

    1. American Regent Laboratories (personal communications and website). March 10 and 30, April 27, May 24, June 22, July 27, August 25, September 27, October 31, November 22, December 19, 2016; January 20, March 6, April 3, May 8, July 6 and 25, September 6 and 18, December 8 and 20, 2017; January 29, February 23, June 11, and September 18 and 21, 2018.
    2. Fresenius Kabi (personal communications). March 10 and 30, April 22, May 23, June 20, July 22, August 18, September 23, October 27, November 21, December 19, 2016; January 20, March 5, April 3 and 28, June 8, July 6 and 19, August 31, September 15, October 4, November 30, December 22, 2017; January 10 and 26, February 15, April 13, May 10 and 25, June 8, July 18, August 29, September 14, and October 5, 20, and 26, November 9, 16, and 29, December 27, 2018; January 11, February 1, 7, and 15, March 1 and 21, May 3 and 30, August 16, September 16 and 19, November 1, 2019; January 3 and 17, March 6, and May 14 and 29, and June 5 and 12, 2020.
    3. Pfizer (personal communications and website). March 10 and 30, April 27, May 24, June 23, July 27, August 25, September 27, October 31, December 19, 2016; January 20, March 8, April 3, May 5, June 9, July 6 and 25, September 1 and 15, October 6, December 8 and 29, 2017; January 8 and 26, February 23, April 13, May 11 and 25, June 8, July 20, August 29, September 14, October 12, 19, and 25, November 9, 16, and 29, December 27, 2018; January 15, February 1, 7, and 15, March 1 and 21, May 3, June 5, August 16, September 17, November 1, 2019; January 3 and 22, March 6, May 15 and 29, and June 12, 2020.
    4. Lexi-Drugs Online. Hudson, OH: Lexi-Comp, Inc.; 2016.

Updated

Updated June 15, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 10, 2016 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.